H1 FY26 Results Release
Filed with ASX · · 6 pages · English
Melbourne, Australia – Vitura Health Limited (ASX: VIT) (Vitura and Company), a leading digital health business, today released its financial results for the half-year ended 31 December 2025 (H1 FY2026). Key Highlights • Total revenue of $67.9 Million (PCP $62.7 Million) – up 8.3%. • Normalised EBITDA (nEBITDA) of $1.9 Million - down from $4.6 Million vs PCP. December 2025 nEBITDA encouraging, wit
In the deck
Earlier from Vitura Health
- H1 FY26 Appendix 4D and Half Year Report
- CEO Transition and Interim Leadership Update
- Declaration of dividend
- FY2025 Financial Results
- ASX Appendix 4E Preliminary Final Report
Later from Vitura Health
- H1 FY26 Investor Presentation
- VIT enters distribution agreement with MedReleaf Australia
- Appointment of Chief Executive Officer
- Doctors on Demand Performance Update
- Business Transformation Update
Follow Vitura Health into a list and get an email when it puts out news.
Follow Vitura Health